For the Inventor, By the Inventor

Enter assignee name

Atlanta, GA, United States of America

Tapestry Pharmaceuticals, Inc.

USPTO Granted Patents = 23

% Expired Patents = 13.0

CIPO Patents = 1

Forward Citations = 81

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

James D McChesney (23 out of 58 patents)

Michael Kurman (14 out of 15 patents)

Manuel R Modiano (14 out of 15 patents)

4. Gilles Hugues Tapolsky (14 out of 27 patents)

5. David Lloyd Emerson (13 out of 15 patents)

6. John L Marshall (12 out of 84 patents)

7. James Ferrara (7 out of 7 patents)

8. Jan J Zygmunt (7 out of 30 patents)

9. Teruna J Siahaan (2 out of 13 patents)

10. Tauseef Ahmed (2 out of 3 patents)

11. Allen Cohn (2 out of 3 patents)

12. Madhavi C Chander (2 out of 13 patents)

13. Christine R Xu (2 out of 2 patents)

14. Sterling K Ainsworth (2 out of 2 patents)

15. John Marshall (2 out of 2 patents)

23 patents: Sort by Forward Citations

1. 12734149 - Taxane analogs for the treatment of brain cancer (2026-09-15),

2. 12583865 - Biologically active taxane analogs and methods of treatment by oral administration (2026-03-24),

3. 11873308 - Biologically active taxane analogs and methods of treatment by oral administration (2024-01-16),

4. 11786504 - Taxane analogs for the treatment of brain cancer (2023-10-17),

5. 11220512 - Biologically active taxane analogs and methods of treatment by oral administration (2022-01-11),

6. 11147793 - Taxane analogs for the treatment of brain cancer (2021-10-19),

7. 10745408 - Biologically active taxane analogs and methods of treatment by oral administration (2020-08-18),

8. 10639293 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2020-05-05),

9. 10450323 - Biologically active taxane analogs and methods of treatment by oral administration (2019-10-22),

10. 10238621 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2019-03-26),

11. 10143677 - Taxane analogs for the treatment of brain cancer (2018-12-04),

12. 9820962 - 9, 10-α, α-oh-taxane analogs and methods for production thereof (2017-11-21),

13. 9802951 - Biologically active taxane analogs and methods of treatment by oral administration (2017-10-31),

14. 9616043 - Taxane analogs for the treatment of brain cancer (2017-04-11),

15. 9402824 - 9,10-α, α-OH-taxane analogs and methods for production thereof (2016-08-02),

Company Overview

Tapestry Pharmaceuticals, Inc. is a biotechnology company based in Atlanta, Georgia, focused on the development of innovative therapeutic solutions. The organization specializes in advancing drug candidates aimed at addressing unmet medical needs, particularly in the fields of oncology and rare diseases. Through its commitment to research and development, Tapestry Pharmaceuticals seeks to leverage cutting-edge technologies to enhance treatment options and improve patient outcomes, contributing to the evolving landscape of healthcare.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

23 Patents

#118 in Atlanta, GA

#275 in Georgia

#14,438 in US

#27,714 in the World

Atlanta, GA, United States of America

Tapestry Pharmaceuticals, Inc.

Forward Citations = 81

16 inventors:

James D McChesney (23 out of 58 patents)

Michael Kurman (14 out of 15 patents)

Manuel R Modiano (14 out of 15 patents)

4. Gilles Hugues Tapolsky (14 out of 27 patents)

5. David Lloyd Emerson (13 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tapestry Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/tapestry-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…